Combining anti-TRPM7 siRNA and gemcitabine improved cytotoxicity, suggesting that modulation of TRPM7 expression could improve treatment response in pancreatic cancer when combined with apoptosis-inducing agents [92]. This evidence concerns the gene TRPM7 and familial pancreatic carcinoma.